3D Bioprinting Market Overview
The 3D bioprinting market is projected to reach USD 4.3 billion by 2028 at 15.8% CAGR says Market Research Future (MRFR). 3D bioprinting is first and foremost a healthcare-based technology that is evolving rapidly to become a multibillion-dollar industry. In simple terms, a biological 3D printer creates simple human tissue structures under controlled laboratory conditions.
It has been estimated that this state-of-the-art technology will be used to create whole human organs for transplantation shortly. Currently, this process is at a start-up stage when partially controlled cell models are done via 3D. This technology is also used to research and develop modern drugs and organic human implants. Thus the 3D bioprinting market has witnessed a boom in the new age of medical procedures.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Share
North America has been dominating the scene regarding extensive usage of this modern medical technology. It has been estimated that nearly 32.4% share of revenue was invested into the 3D bioprinting market in this region. The significant increase is due to the fact that IT-based healthcare technologies are integrated into medical systems. Given the current pandemic situation, the U.S. has increased the use of this technology in vaccine development and testing.
The Asia-Pacific region has risen 24.3% to invest in this modern medical miracle. China and Japan have invested significantly in this technology since the onset of the pandemic, leading to a decline in organ donation statistics. The key companies leading in the manufacturing of 3D bioprinting technology are Fluicell, Cellink Global, Cyfuse Biomedical K.K., Poietis, Envisiontech Inc., and Vivax Bio LLC.
3D Bioprinting Market Growth
Not just organ transplantation, but 3D bioprinting has seen an upward trend during the COVID-19 situation. The global health system has fallen apart and there are few organ donors for patients in need of emergency transplants. Manufacturing units are accelerating the process to address this deficiency. Manufacturers in the United States are even using this leading-edge technology to produce nasal swabs for COVID-19 kits at a rate of 100,000 swabs per day.
It has recently entered the broad spectrum of creating 3D designed PPE kits, personal shield masks, medical testing devices and visualization aids. Today, 3D bio-printing manufacturers are producing 5,000 full-face masks per day to cope with the epidemic. They are also actively creating 3-D printed respirators and ventilators to address the shortage in many health care facilities globally.
It has been reported that scientific advancement has been made with this technology by CLECELL a 3D bioprinting company. It has developed a tissue liner known as the respiratory epithelium that allows the blockage of pathogens into the respiratory tract by lining as the tissue. It is also known to protect the respiratory tract from tissue injuries and infections, making it a groundbreaking discovery during the pandemic period. There is a strong demand for respiratory epithelium to protect the lungs and respiratory tract from new coronavirus infection. As a result, this cutting-edge medical technology proved to be a boon during the global health crisis.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
3D Bioprinting Market Value
This latest technology is attributed to greater speed and accuracy and is used to regenerate human cells, print vascular muscles and screen for toxicity. It is estimated that the vast majority of the population depends on medical pills and capsules, thus speeding up the research and development of these drugs thanks to 3D bioprinting techniques. As tissue and cell regeneration becomes the “new standard”, this medical segmentation technology is expected to increase exponentially in the future.
The top key players in 3d bioprinting market are EnvisionTEC GmbH (Germany), Allevi (U.S.), Poietis (France), Nano3D Biosciences Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), Cellink AB (Sweden), FUJIFILM Wako Automation Corporation (U.S.), REGENHU Ltd. (Switzerland), Organovo Holdings Inc. (U.S.), Stratasys Ltd. (U.S.),Regenovo Biotechnology Co. Ltd. (China) and Aspect Biosystems Ltd. (Canada).
Creating an entire, healthy human organ with 3D bioprinting is not far off. This ground-breaking medical technology will be the future of biological sciences and the birth of human tissue cells made in laboratories. This will resolve serious illnesses and extend life expectancy for seniors.
Browse Related Reports at:
Cardiac Resynchronization Therapy Market Research Report – Global Forecast till 2027
Liver Cirrhosis Treatment Market Research Report – Global Forecast till 2027
Light Therapy Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071